News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Cmed Appoints Mac McElroy as CEO of US Organization

9/21/2010 11:03:04 AM

Durham, N.C.--(BUSINESS WIRE)--Cmed Group which combines clinical research services with a leading-edge clinical data capture and management system, has strengthened its senior management team with the appointment of Mac McElroy as Chief Executive Officer (CEO) of its US organization, Cmed Inc.

“The addition of Mac along with our recent appoint of Andrew Kellett as our Group CFO [Chief Finance Officer] means Cmed now has a particularly strong and impressive senior management team” McElroy formerly served as Executive Director of Strategic Development, Americas for Chiltern International for over two years. Prior to this he was Vice President, Corporate Development for six years and was a member of the Executive Management team of CTMS, Inc. McElroy holds BA and Master’s degrees. In his early career McElroy grew his management experience by successfully opening and establishing new long term care facilities. Later he spent ten years as Vice President for Institutional Advancement for a private liberal arts college.

His appointment strengthens Cmed’s management team as the group accelerates the global expansion of its flagship IT product Timaeus, a next-generation clinical data capture and management solution which is already delivering critical benefits in a number of major international clinical trials.

Cmed Global Chief Executive David Connelly said: “We are delighted to welcome Mac McElroy to the Cmed team. Mac brings a breadth of experience, knowledge and skills which will be very valuable not only to Cmed in the US, but the company as a whole. He has a great track record of developing strong relationships with clients and partners, and driving quality and growth.”

“The addition of Mac along with our recent appoint of Andrew Kellett as our Group CFO [Chief Finance Officer] means Cmed now has a particularly strong and impressive senior management team,” added Connelly.

McElroy commented: “I am extremely pleased to be leading Cmed, Inc. Cmed’s consistent track record for delivering top quality clinical research services with integrity is impressive.”

Cmed’s innovative clinical data management system Timaeus is being used to capture and manage data in real-time across six continents, for a broad range of clinical trials. Used by Cmed’s CRO division and also licensed to clients for their own use, Timaeus delivers key advantages over existing data capture and management systems. Its modern, e cloud and mobile friendly architecture allows sites to work 24/7 without interruption- including rolling out of amendments, have all edit checks fire live without performance issues and it enables clinical trials to be conducted in even remote locations (e.g. in the developing world) by managing electronic data reliably, and at high speed, using only a standard mobile phone connection.

About Cmed – The Cmed Group of companies, formed by pharmaceutical industry executives, is based in Horsham, UK, New Jersey and North Carolina, USA and Timisoara, Romania. Cmed is a unique combination of a full service CRO and an eClinical solutions provider. Cmed CRO offers services across a wide range of therapeutic areas and challenging geographical locations; these include project management, clinical monitoring, clinical data management and biostatistics. Our skilled workforce combines clinical expertise and innovative processes with the Timaeus eClinical platform to deliver a smarter approach to the conduct of clinical trials. Cmed Technology provides Timaeus, a next-generation solution for on-demand trial configuration, EDC, monitoring, medical coding, clinical data management and reporting.

For more information visit:,

Contacts Cmed Media Contact: Jane Stubbington 01403 756416

Read at

comments powered by Disqus